Cigna Group — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Cigna Group filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $274.90B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $247.12B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $195.27B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $180.52B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $174.07B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $160.40B | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $38.25B | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $38.56B | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $38.82B | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $37.95B | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.96B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.43B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $5.16B | Feb 26, 2026 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.20B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $9.42B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $8.54B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $8.45B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $7.94B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $8.15B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $8.08B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $4.16B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $3.94B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $3.09B | Feb 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.62B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $14.84B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $14.82B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $13.17B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $13.01B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $14.07B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $14.05B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $11.93B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $10.03B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $9.79B | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.60B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $10.36B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $11.81B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $8.66B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $7.19B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $10.35B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $9.49B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $3.77B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $4.09B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $4.03B | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $1.05B | Feb 27, 2020 |
| FY2019 | Dec 31, 2018 | $528.00M | Feb 27, 2020 |
| FY2019 | Dec 31, 2017 | $471.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $461.00M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $157.92B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $155.88B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $152.76B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $143.89B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $154.89B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $155.45B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $155.77B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $153.23B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $61.76B | Feb 28, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $116.05B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $114.64B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $106.41B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $99.13B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $107.71B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $105.07B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $110.40B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $112.15B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $48.00B | Feb 28, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.71B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $41.03B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $46.22B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $44.68B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $47.11B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $50.32B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $45.34B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $41.03B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $13.71B | Feb 28, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.92B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $44.37B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $44.26B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $45.81B | Feb 27, 2025 |
| FY2022 | Dec 31, 2021 | $45.81B | Feb 23, 2023 |
| FY2022 | Dec 31, 2020 | $44.65B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $44.60B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $44.51B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $6.16B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $5.98B | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.87B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $43.52B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $41.65B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $37.94B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $32.59B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $28.58B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $20.16B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $15.09B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $15.80B | Feb 28, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.68B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $7.55B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $7.82B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $5.92B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $5.08B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $10.18B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $4.62B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $3.86B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.97B | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $3.19B | Feb 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 12 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 17 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 21 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 15 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 23 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 2 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 3 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 3 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 3 | Feb 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 12 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 17 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 21 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 15 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 22 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 2 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 3 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 3 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 3 | Feb 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 263.46M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 273.79M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 292.50M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | 298.68M | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | 322.95M | Feb 27, 2025 |
| FY2023 | Dec 31, 2020 | 354.77M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | 372.53M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | 380.92M | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | 0 | Feb 25, 2021 |
| FY2018 | Dec 31, 2016 | 0 | Feb 28, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.61B | Feb 26, 2026 |
| FY2025 | Dec 18, 2025 | $396.00M | Feb 26, 2026 |
| FY2025 | Sep 18, 2025 | $402.00M | Feb 26, 2026 |
| FY2025 | Jun 18, 2025 | $401.00M | Feb 26, 2026 |
| FY2025 | Mar 20, 2025 | $412.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.57B | Feb 26, 2026 |
| FY2025 | Dec 19, 2024 | $384.00M | Feb 26, 2026 |
| FY2025 | Sep 19, 2024 | $390.00M | Feb 26, 2026 |
| FY2025 | Jun 20, 2024 | $392.00M | Feb 26, 2026 |
| FY2025 | Mar 21, 2024 | $401.00M | Feb 26, 2026 |